- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Growth Stocks at a Reasonable Price
Global Pharmaceuticals & Biotech Growth Stocks at a Reasonable Price
UPDATED Jun 30, 2022
Growing companies available at a reasonable price.
48 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NATCOPHARMNATCO Pharma | ₹650.40 | 0.9% | -43.4% | ₹118.6b | ₹858.42 | PE69.8x | E71.1% | 0.7% | ||
| BXPHARMABeximco Pharmaceuticals | ৳154.60 | -2.6% | -12.8% | ৳69.0b | ৳182.00 | PE12x | E12.3% | 2.3% | ||
| 4579RaQualia Pharma | JPÂ¥701.00 | -0.7% | -31.9% | JPÂ¥14.8b | JPÂ¥1,900.00 | PE32.9x | E33.9% | n/a | ||
| 532482Granules India | ₹278.50 | 8.5% | -18.2% | ₹67.7b | ₹307.50 | PE16.7x | E17.6% | 0.5% | ||
| 6826Shanghai Haohai Biological Technology | HK$41.50 | 5.3% | -58.1% | HK$18.6b | HK$69.23 | PE19.6x | E20.6% | 2.0% | ||
| 300406Beijing Strong Biotechnologies | CNÂ¥17.37 | -0.9% | -13.7% | CNÂ¥10.2b | n/a | PE26.1x | E27.6% | 0.6% | ||
| SQURPHARMASquare Pharmaceuticals | ৳216.70 | 0.8% | 0.6% | ৳192.1b | ৳324.40 | PE10.4x | E11.4% | 2.8% | ||
| A145020Hugel | â‚©104,500.00 | -4.3% | -56.7% | â‚©1.2t | â‚©184,142.86 | PE22.9x | E25.4% | n/a | ||
| HZNPHorizon Therapeutics | US$79.76 | -3.8% | -17.4% | US$18.3b | US$138.64 | PE21.3x | E24.3% | n/a | ||
| PBPProbiotec | AU$2.23 | 1.4% | 7.2% | AU$183.0m | AU$3.04 | PE21.9x | E25.2% | 2.2% | ||
| SUPNSupernus Pharmaceuticals | US$28.92 | 1.9% | -7.9% | US$1.5b | US$35.50 | PE21.1x | E24.4% | n/a | ||
| A214450PharmaResearch | â‚©65,700.00 | -10.5% | -25.8% | â‚©672.4b | â‚©105,000.00 | PE15x | E17.5% | 0.9% | ||
| EXELExelixis | US$20.82 | -2.4% | 11.7% | US$6.7b | US$26.56 | PE22.4x | E27.0% | n/a | ||
| SLGLSol-Gel Technologies | US$4.10 | -9.4% | -65.5% | US$94.8m | US$17.67 | PE56.2x | E68.3% | n/a | ||
| HYPE3Hypera | R$38.04 | -1.9% | 11.7% | R$24.0b | R$45.63 | PE14.5x | E18.2% | 3.2% | ||
| HALOHalozyme Therapeutics | US$44.00 | -6.0% | -5.1% | US$6.1b | US$55.00 | PE13.9x | E17.8% | n/a | ||
| 524348Aarti Drugs | ₹397.60 | 1.2% | -45.4% | ₹37.4b | ₹477.00 | PE18x | E23.1% | 0.3% | ||
| COPNCosmo Pharmaceuticals | CHF46.80 | 1.2% | -45.2% | CHF781.9m | CHF85.90 | PE36.1x | E46.7% | 2.0% | ||
| LAB BGenomma Lab Internacional. de | Mex$20.10 | -1.5% | -0.05% | Mex$20.3b | Mex$26.31 | PE13.8x | E17.9% | 1.9% | ||
| A086450DongKook Pharmaceutical | â‚©19,350.00 | 3.5% | -30.9% | â‚©854.8b | â‚©29,000.00 | PE16.7x | E23.4% | 0.9% | ||
| 4105TTY Biopharm | NT$71.80 | -1.4% | -14.7% | NT$17.9b | NT$73.00 | PE20.9x | E29.7% | 4.2% | ||
| ATRSAntares Pharma | US$5.59 | 0.2% | 39.4% | US$955.1m | US$6.36 | PE23.8x | E34.0% | n/a | ||
| RCUSArcus Biosciences | US$25.34 | 1.4% | -8.0% | US$1.8b | US$57.20 | PE31.6x | E47.1% | n/a | ||
| 460Sihuan Pharmaceutical Holdings Group | HK$1.28 | 1.6% | -59.1% | HK$11.9b | HK$3.91 | PE24.5x | E36.7% | 9.9% |